Clinical outcomes of GLP-1RA in kidney disease: Current evidence and ongoing trials
Frederik Persson shows evidence of renoprotective effects with GLP-1RA treatment, by discussing various small clinical trials as well as CVOTs with GLP-1RAs.
Video navigation menu
- Trials and studies on GLP-1RAs in renal patient populations 1:19
- Renal outcomes with GLP-1RAS in various trials 6:21
- Ongoing trials with GLP-1RAs examining renal outcomes 11:45
This lecture by Frederik Persson was part of a CME-accredited symposium "Impacting progression and outcomes of DKD: Translating novel insights with GLP-1 RA to practice" held during ERA EDTA 2019 in Budapest, Hungary.
Frederik Persson, MD, Senior researcher at Steno Diabetes Center, Copenhagen, Denmark.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk A/S.
This is available as accredited online CME for members. Click the button below to enroll:Enroll
Share this page with your colleagues and friends: